These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3393555)

  • 21. Neoadjuvant therapy of carcinoma of the bladder.
    deVere White RW
    Semin Urol; 1990 Aug; 8(3):197-200. PubMed ID: 2204981
    [No Abstract]   [Full Text] [Related]  

  • 22. Adjuvant methotrexate, vinblastine and cisplatin chemotherapy for invasive transitional cell carcinoma: Taiwan experience.
    Wei CH; Hsieh RK; Chiou TJ; Chen KK; Chang LS; Chen PM
    J Urol; 1996 Jan; 155(1):118-21. PubMed ID: 7490806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study of neoadjuvant chemotherapy for invasive bladder cancer with MEC (methotrexate, epirubicin, cisplatin) therapy].
    Ohuchi H; Noguchi S; Takase K; Kawakami S; Ikeda I; Saito K; Yao M; Masuda M; Kubota Y; Hosaka M
    Hinyokika Kiyo; 2001 Apr; 47(4):241-6. PubMed ID: 11411097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathologic response and long term results of preoperative M-VAC regimen in regionally advanced transitional cell carcinoma of the bladder.
    Abi-Aad AS; Stenzl A; Figlin R; deKernion JB
    Acta Urol Belg; 1993 Dec; 61(4):13-6. PubMed ID: 8296684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phase-II study of neoadjuvant chemotherapy in T3-4N0-XM0 transitional cell carcinoma of the bladder: a preliminary analysis.
    Splinter TA; Schröder FH; Denis L; Newling D; Jacqmin D; Hall RR; de Pauw M
    Eur Urol; 1988; 14 Suppl 1():24-6. PubMed ID: 3181236
    [No Abstract]   [Full Text] [Related]  

  • 26. [Preoperative or neoadjuvant chemotherapy. Our experience with 37 patients].
    Escudero Barrilero A; Fernández E; Crespo C
    Arch Esp Urol; 1991 May; 44(4):379-92. PubMed ID: 2064440
    [No Abstract]   [Full Text] [Related]  

  • 27. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
    Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neoadjuvant chemotherapy for bladder transitional cell carcinoma: a new standard of care?
    Mazhar D; Ali N; Ngan S
    Future Oncol; 2007 Feb; 3(1):5-8. PubMed ID: 17280495
    [No Abstract]   [Full Text] [Related]  

  • 29. [Neoadjuvant and adjuvant chemotherapy of bladder cancer].
    Kuroda M; Kotake T
    Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():362-9. PubMed ID: 7986116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [[Neoadjuvant chemotherapy (cisplatin, doxorubicin, cyclophosphamide) in the treatment of invasive urothelial tumors of the bladder. Preliminary results of a prospective study concerning 22 patients].
    Trifard F; Chrétien Y; Vallantin X; Collet C; Lachand AT; Dufour B
    Ann Urol (Paris); 1988; 22(3):216-9. PubMed ID: 3401004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapidly alternating chemotherapy and radiotherapy instead of cystectomy for the treatment of muscle-invasive carcinoma of the urinary bladder: long term results of a pilot study.
    Vikram B; Chadha M; Malamud SC; Hecht H; Grabstald H
    Cancer; 1998 Mar; 82(5):918-22. PubMed ID: 9486582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined chemotherapy and irradiation for transitional cell cancer of the bladder: a review.
    Beuzeboc P; Pontvert D; Pouillart P; Cosset JM
    J Infus Chemother; 1995; 5(4):218-20. PubMed ID: 8934733
    [No Abstract]   [Full Text] [Related]  

  • 33. [Conservative treatment with chemotherapy and radiotherapy in bladder cancer invading the muscle: preliminary results of a prospective study].
    Zapatero A; Pinar B; Arellano R; López M; Marín A; Jiménez U; Pérez Torrubia A
    Arch Esp Urol; 1997 Jun; 50(5):448-54; discussion 454-6. PubMed ID: 9382586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Conservative treatment of infiltrating cancer of the bladder: neoadjuvant chemotherapy and radiotherapy].
    Prié L; Gaston R; Ferrière JM; Richaud P; Bui BN; Guillou ML
    Cancer Radiother; 1998 Apr; 2 Suppl 1():62s-66s. PubMed ID: 9749081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A case report of a young patient with invasive bladder cancer].
    Nakashima M; Nishiyama H; Yagihashi Y; Yamamoto S; Kamoto T; Habuchi T; Ogawa O
    Hinyokika Kiyo; 2003 Dec; 49(12):745-8. PubMed ID: 14978958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microcapsule chemoembolization therapy: a new approach to bladder cancer.
    Kato T
    Prog Clin Biol Res; 1984; 162B():359-63. PubMed ID: 6209723
    [No Abstract]   [Full Text] [Related]  

  • 37. Proton beam therapy for invasive bladder cancer: a prospective study of bladder-preserving therapy with combined radiotherapy and intra-arterial chemotherapy.
    Hata M; Miyanaga N; Tokuuye K; Saida Y; Ohara K; Sugahara S; Kagei K; Igaki H; Hashimoto T; Hattori K; Shimazui T; Akaza H; Akine Y
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1371-9. PubMed ID: 16580495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination chemotherapy of cisplatin, methotrexate, vinblastine, and high-dose tamoxifen for transitional cell carcinoma.
    Hsu CH; Chen J; Wu CY; Cheng AL; Pu YS
    Anticancer Res; 2001; 21(1B):711-5. PubMed ID: 11299831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic chemotherapy in the management of advanced bladder cancer.
    Hall RR
    Arch Esp Urol; 1990; 43 Suppl 2():193-6. PubMed ID: 2096778
    [No Abstract]   [Full Text] [Related]  

  • 40. Chemotherapy of metastatic bladder cancer.
    Yagoda A
    Cancer; 1980 Apr; 45(7 Suppl):1879-88. PubMed ID: 7189443
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.